These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 34694173)
1. Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats. Han M; Lian J; Su Y; Deng C J Psychopharmacol; 2022 Feb; 36(2):202-213. PubMed ID: 34694173 [TBL] [Abstract][Full Text] [Related]
2. The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats. Lian J; Deng C Pharmacol Biochem Behav; 2020 Apr; 191():172878. PubMed ID: 32112786 [TBL] [Abstract][Full Text] [Related]
3. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels. Weston-Green K; Huang XF; Lian J; Deng C Eur Neuropsychopharmacol; 2012 May; 22(5):364-73. PubMed ID: 21982116 [TBL] [Abstract][Full Text] [Related]
4. Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways. Liu X; Lian J; Hu CH; Deng C Pharmacol Res; 2015 Oct; 100():36-46. PubMed ID: 26218603 [TBL] [Abstract][Full Text] [Related]
5. Olanzapine Modulate Lipid Metabolism and Adipose Tissue Accumulation via Hepatic Muscarinic M3 Receptor-Mediated Alk-Related Signaling. Su Y; Cao C; Chen S; Lian J; Han M; Liu X; Deng C Biomedicines; 2024 Jun; 12(7):. PubMed ID: 39061977 [TBL] [Abstract][Full Text] [Related]
6. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation. Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361 [TBL] [Abstract][Full Text] [Related]
7. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications. Lian J; Huang XF; Pai N; Deng C Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184 [TBL] [Abstract][Full Text] [Related]
8. Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways. Lian J; Huang XF; Pai N; Deng C Psychoneuroendocrinology; 2014 Oct; 48():77-86. PubMed ID: 24992721 [TBL] [Abstract][Full Text] [Related]
9. Effects of cevimeline on excitability of parasympathetic preganglionic neurons in the superior salivatory nucleus of rats. Mitoh Y; Ueda H; Ichikawa H; Fujita M; Kobashi M; Matsuo R Auton Neurosci; 2017 Sep; 206():1-7. PubMed ID: 28600120 [TBL] [Abstract][Full Text] [Related]
10. A Novel Synthetic Interfering Peptide Tat-3L4F Attenuates Olanzapine-Induced Weight Gain Through Disrupting Crosstalk Between Serotonin Receptor 2C and Protein Phosphatase and Tensin Homolog in Rats. Wang Y; Wang D; Chen Y; Fang X; Yu L; Zhang C Int J Neuropsychopharmacol; 2020 Nov; 23(8):481-490. PubMed ID: 32710540 [TBL] [Abstract][Full Text] [Related]
11. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome. Tsuboi H; Matsumoto I; Wakamatsu E; Nakamura Y; Iizuka M; Hayashi T; Goto D; Ito S; Sumida T Clin Exp Immunol; 2010 Oct; 162(1):53-61. PubMed ID: 20731676 [TBL] [Abstract][Full Text] [Related]
12. Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats. Babic I; Sellers D; Else PL; Nealon J; Osborne AL; Pai N; Weston-Green K J Psychopharmacol; 2021 Mar; 35(3):284-302. PubMed ID: 33570012 [TBL] [Abstract][Full Text] [Related]
13. Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats. Yang CP; Wang YY; Lin SY; Hong YJ; Liao KY; Hsieh SK; Pan PH; Chen CJ; Chen WY Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717287 [TBL] [Abstract][Full Text] [Related]
14. Neuropharmacology of Cevimeline and Muscarinic Drugs-Focus on Cognition and Neurodegeneration. Oleksak P; Novotny M; Patocka J; Nepovimova E; Hort J; Pavlik J; Klimova B; Valis M; Kuca K Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445613 [TBL] [Abstract][Full Text] [Related]
15. Effects of pilocarpine and cevimeline on Ca2+ mobilization in rat parotid acini and ducts. Ono K; Inagaki T; Iida T; Hosokawa R; Inenaga K J Med Invest; 2009; 56 Suppl():375. PubMed ID: 20224229 [TBL] [Abstract][Full Text] [Related]
16. Cevimeline enhances the excitability of rat superior salivatory neurons. Ueda H; Mitoh Y; Ichikawa H; Kobashi M; Yamashiro T; Matsuo R J Med Invest; 2009; 56 Suppl():267-9. PubMed ID: 20224198 [TBL] [Abstract][Full Text] [Related]
18. Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor. Weston-Green K; Huang XF; Deng C CNS Drugs; 2013 Dec; 27(12):1069-80. PubMed ID: 24114586 [TBL] [Abstract][Full Text] [Related]
19. Teaching an Old Drug New Tricks: Agonism, Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine Receptor. Pronin AN; Wang Q; Slepak VZ Mol Pharmacol; 2017 Nov; 92(5):601-612. PubMed ID: 28893976 [TBL] [Abstract][Full Text] [Related]
20. Degradation of submandibular gland AQP5 by parasympathetic denervation of chorda tympani and its recovery by cevimeline, an M3 muscarinic receptor agonist. Li X; Azlina A; Karabasil MR; Purwanti N; Hasegawa T; Yao C; Akamatsu T; Hosoi K Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G112-G123. PubMed ID: 18450949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]